
Incorporated in 2021, Earkart Limited manufactures and distributes modern hearing aids and related accessories at affordable prices across India. The company offers hearing solutions through a network of partners and clinics across India, which sell both domestic and global hearing aid brands. The company produces its own products alongside trading third-party items, such as walkers and MSIED/TLM kits for the physically disabled. As a reputed GeM supplier, it supplies clients such as ALIMCO. Government sales made up 69.32% of FY25 revenue, out of which own brand products accounted for 68.88%, primarily hearing aids (56.65%). Meanwhile, private players (retailers/distributors) made up 28.96%, and 49 shop-in-shop (SIS) clinics in 22 cities accounted for 1.72%. The company started the SIS model in April 2024. Domestic market led sales (99.20%), with Uttar Pradesh(76.83%) dominating, alongside exports to China, Nigeria, etc.
Bidding starts for all investor categories
Last day to place your bid
Share allotment finalised
Refunds credited for non-allottees
Allotted shares credited to demat account
Shares list on NSE / BSE
Post-close dates are indicative as per SEBI T+3 listing framework and may change per registrar updates.
| Investor Type | Min Lots | Min Shares | Min Amount | Max Lots | Max Amount | Notes |
|---|---|---|---|---|---|---|
| Retail / Individual | 1 | 1000 | ₹135,000 | 1 | ₹135,000 | 1 lot only |
| HNI | 2 | 2000 | ₹270,000 | 2 | ₹270,000 | Min 2 lots |
| Category | Reservation | Shares Offered | Amount (₹ Cr) | Shares Bid | Subscribed | Allotment % |
|---|---|---|---|---|---|---|
| QIB | 50% | 1,814,815 | 24.5 | 0 | 0.00x | 100% |
| NII | 15% | 544,445 | 7.35 | 0 | 0.00x | 100% |
| Retail | 35% | 1,270,371 | 17.15 | 0 | 0.00x | 100% |
Retail is a lottery-based allotment when oversubscribed; QIB/NII get pro-rata. Probability ≈ 1 / subscription times (100% if under-subscribed).